GLP-1 drugs are easier to get than ever, even as reports of overdoses, severe reactions, vision loss, and multibillion-dollar lawsuits continue to mount. Del and Jefferey look at how quickly these drugs are being prescribed, how little time some providers spend with patients, and why proper dosing and medical follow-up may make all the difference.

Airdate: September 17, 2026